Non-Invasive Glucose Monitoring Devices Market Size & Share, by Technology (Optical, Transdermal, Enzymatic); Modality (Wearable, Non-Wearable); End-User (Hospitals & Clinics, Ambulatory Surgical Centres, Homecare) - Global Supply & Demand Analysis, Growth Forecasts, Statistics Report 2024-2036

  • Report ID: 2942
  • Published Date: Sep 23, 2024
  • Report Format: PDF, PPT

Global Market Size, Forecast, and Trend Highlights Over 2024-2036

Non-Invasive Glucose Monitoring Devices Market size was valued at USD 27.03 million in 2023 and is poised to reach USD 354.73 million by the end of 2036, registering around 21.9% CAGR during the forecast period i.e., between 2024-2036. In the year 2024, the industry size of non-invasive glucose monitoring devices is assessed at USD 31.77 million.

Extensive research associated with diabetes management globally, along with the growing investment in the development of advanced monitoring systems are expected to fuel the progress of this market in the future. The growth of the market can also be attributed to factors such as the increasing geriatric population and the rising prevalence of diabetes mellitus amongst individuals on a global level. According to the data collected from The International Diabetes Federation (IDF), in 2019, 463 million estimated number of adults aged between 20-79 years were suffering from diabetes and by 2045, the number is expected to rise to 700 million.


Global-Non-Invasive-Glucose-Monitoring-Market-Outlook
Get more information on this report: Request Free Sample PDF

Non-Invasive Glucose Monitoring Devices Sector: Growth Drivers and Challenges

Growth Drivers

  • Rising Prevalence of Diabetes Mellitus
  • Increasing Geriatric Population in the World

Challenges

  • Expensive Non-Invasive Glucose-Monitoring Devices
  • Lack of Accuracy & Sensitivity of the Devices

Non-Invasive Glucose Monitoring Devices Market: Key Insights

Base Year

2023

Forecast Year

2024–2036

CAGR

21.9%

Base Year Market Size (2023)

USD 27.03 million

Forecast Year Market Size (2036)

USD 354.73 million

Regional Scope

  • North America (U.S., and Canada)
  • Latin America (Mexico, Argentina, Rest of Latin America)
  • Asia-Pacific (Japan, China, India, Indonesia, Malaysia, Australia, Rest of Asia-Pacific)
  • Europe (U.K., Germany, France, Italy, Spain, Russia, NORDIC, Rest of Europe)
  • Middle East and Africa (Israel, GCC North Africa, South Africa, Rest of the Middle East and Africa)
Get more information on this report: Request Free Sample PDF

Non-Invasive Glucose Monitoring Devices Segmentation

The non-invasive glucose monitoring devices market is segmented based on technology into optical, transdermal, enzymatic, and others, out of which, the optical segment is anticipated to grab the largest share by the end of 2029 on account of higher positive diagnosis rates and better efficiency of this type of glucose-monitoring. Moreover, increasing government approval of glucose monitoring systems globally is also projected to contribute to the growth of the segment during the forecast period.

On the basis of modality, the wearable segment in the non-invasive glucose monitoring devices market is projected to grow with a significant CAGR over the forecast period. The growth of the segment can be attributed to the fact that patients are influenced towards needle-free and painless glucose monitoring systems. As a result, a considerable portion of the population with diabetes mellitus on a global level tend to choose wearable glucose-monitoring devices.

Based on end-user, the homecare segment held the largest share in the non-invasive glucose monitoring devices market on the back of growing advancements in connected devices in self healthcare management of diabetes mellitus. Moreover, increasing adoption of self-management devices by the individuals is further driving the market’s growth. 

 

Our in-depth analysis of the global market includes the following segments:

          By Technology

  • Optical
    • Near-infrared reflectance spectroscopy (NIRS)
    • Raman spectroscopy
    • Optical coherence tomography (OCT)
    • Others
  • Transdermal
  • Enzymatic
  • Others

          By Modality

  • Wearable
  • Non-Wearable

          By End-user

  • Hospitals & Clinics
  • Ambulatory surgical centers (ASC)
  • Homecare

Want to customize this research report as per your requirements? Our research team will cover the information you require to help you take effective business decisions.

Customize this Report

Non-Invasive Glucose Monitoring Devices Industry - Regional Synopsis

Geographically, the non-invasive glucose monitoring devices market is segmented into North America, Latin America, Europe, Asia Pacific and the Middle East & Africa region. The market in the Asia Pacific industry is poised to dominate majority revenue share by 2036, owing to increasing prevalence of diabetes mellitus and rising competition among major companies in the region. Furthermore, the market in North America is evaluated to occupy the largest share in terms of revenue during the forecast period, owing to the growing investment of governmental and non-governmental agencies in diabetes management research, accompanied by the presence of leading healthcare service providers in the region. Along with this, North America also leads in terms of well-established medical infrastructure that allows proper diagnosis, which is also expected to contribute to the non-invasive glucose monitoring devices market growth in the region. Alternatively, the market in Europe is also anticipated to occupy a significant share in the global non-invasive glucose-monitoring market on account of its proven success in terms of technology development and a high number of cases of diabetes mellitus in the region. As per the analysis of the Organisation for Economic Cooperation and Development (OECD), approximately 32.3 million adults in the European Union were diagnosed with diabetes in the year 2019.

Research Nester
Non-Invasive-Glucose-Monitoring-Market-Share
Get more information on this report: Request Free Sample PDF

Companies Dominating the Non-Invasive Glucose Monitoring Devices Landscape

    • DiaMonTech AG
      • Company Overview
      • Business Strategy
      • Key Product Offerings
      • Financial Performance
      • Key Performance Indicators
      • Risk Analysis
      • Recent Development
      • Regional Presence
      • SWOT Analysis
    • Nemaura Medical
    • Metamaterial Inc.
    • BOYDSense SAS
    • LifePlus, Inc.
    • Integrity Applications
    • AerBetic  
    • RSP Systems A/S
    • Cnoga Medical Ltd.

Author Credits:  Radhika Pawar


  • Report ID: 2942
  • Published Date: Sep 23, 2024
  • Report Format: PDF, PPT

Frequently Asked Questions (FAQ)

Rising prevalence of diabetes mellitus and increasing elderly population are the key factors driving market growth.

The market is anticipated to attain a high CAGR over the forecast period, i.e., 2021-2029.

Costly non-invasive glucose-monitoring devices and lack of accuracy and sensitivity are estimated to hamper market growth.

The market in Asia Pacific region will provide ample growth opportunities owing to the increasing awareness about non-invasive glucose-monitoring systems.

The major players dominating the Non-Invasive Glucose-Monitoring market are DiaMonTech AG, Nemaura Medical, Metamaterial Inc., BOYDSense SAS, LifePlus, Inc., Cnoga Medical Ltd., among others.
Non-Invasive Glucose-Monitoring Market Report Scope
logo
  GET A FREE SAMPLE

FREE Sample Copy includes market overview, growth trends, statistical charts & tables, forecast estimates, and much more.

 Request Free Sample Copy

Have questions before ordering this report?

Inquiry Before Buying
Inquiry Before Buying Request Free Sample